[What common grounds exist in the pathomechanism of Sjögren disease and associated hematologic diseases? From autoreactive B cell activation and T cell cooperation to B-cell lymphoma. Pathogenesis of lymphoproliferations in patients with Sjögren syndrome].
Wagner
U
U
Medizinische Klinik IV Zentrum für Innere Medizin Abteilung Rheumatologie Härtelstr. 16-18, 04107 Leipzig, Germany. wagu@medizin.uni-leipzig.de
Seidel
W
W
Häntzschel
H
H
D000818:Animals; D017209:Apoptosis / Q000276:immunology; D001324:Autoantigens / Q000276:immunology*; D053265:B-Cell Activation Factor Receptor; D001402:B-Lymphocytes / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002471:Cell Transformation, Neoplastic / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D016393:Lymphoma, B-Cell / Q000276:immunology*; D008565:Membrane Proteins; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D012859:Sjogren's Syndrome / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D001324:Autoantigens; D053265:B-Cell Activation Factor Receptor; D008565:Membrane Proteins; D018124:Receptors, Tumor Necrosis Factor; C435926:TNFRSF13C protein, human
Welche Gemeinsamkeiten bestehen im Pathomechanismus von Morbus Sjögren und den damit assoziierten hämatologischen Erkrankungen? Von autoreaktiver B-Zell-Aktivierung und T-Zell-Hilfe zum B-Zell-Lymphom. Pathogenese von Lymphoproliferationen bei Patienten mit Sjögren-Syndrom.